McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales
Dec 13, 07:15 PM
AP Washington correspondent Sagar Meghani reports McKinsey & Company has agreed to pay $650 million for helping Purdue Pharma boost OxyContin sales.